Last Updated: October 3, 2025
Analyzing Management
Leadership at public companies serves as a crucial variable for hedge funds and asset managers during both initial due diligence and continuous risk assessment. ManagementTrack offers a systematic approach that eliminates distractions, highlighting distinct strengths and weaknesses, identifying warning signs and positive indicators, and establishing a straightforward connection between CEO actions and financial performance.
CEO Just-Bomholt’s skills face execution risk on China and FDA catalysts.
Analysis of Elekta CEO Jakob Just-Bomholt
While Jakob Just-Bomholt’s proven margin and product launch skills are valuable, his lack of specific China and FDA experience introduces execution risk on key growth and regulatory catalysts for Elekta.
Management evaluated Jakob Just-Bomholt’s track record and skillset against the following key factors for EKTA.B-SE:
- Executing the guided H2 sales recovery in China.
- Defending margins against tariff and FX headwinds.
- Sustaining Evo/ONE launch momentum to expand margins.
- Securing US FDA Approval for Elekta Evo.
Jakob Just-Bomholt’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
Given the recurring tension between Just-Bomholt’s successful high-level strategic moves and documented on-the-ground operational stumbles, how will he balance the strategic imperative to drive adoption of the new Evo/ONE platform against the risk of repeating past execution failures where software and support issues undermined an otherwise successful product launch?
Question #2
When faced with the choice between protecting margins through the disciplined cost-cutting seen at Falck and pursuing the aggressive, top-line growth strategy from APM Terminals that previously led to margin erosion, which playbook is Just-Bomholt more likely to deploy at Elekta?
Question #3
Will Just-Bomholt’s proven ability to resolve complex legal and reputational crises translate to effectively managing the stalled FDA approval process, or does his playbook lack the specific nuance and detailed follow-through required for engaging with a scientific regulatory body?
Why Do Investors Use ManagementTrack?
Q: How does ManagementTrack assess the capabilities of Jakob Just-Bomholt at EKTA.B-SE?
A: Through its proprietary career analysis and interviews with former colleagues, ManagementTrack establishes an executive’s track record, identifying key strengths and weaknesses. This profile is then measured against EKTA.B-SE’s most critical challenges, such as executing a sales recovery in China, defending margins against tariff and FX headwinds, sustaining momentum for the Evo/ONE product launch, and securing US FDA approval for the Elekta Evo.
Q: What additional methods does ManagementTrack use to link executive teams to future corporate performance?
A: ManagementTrack utilizes proprietary models to flag abnormal levels of executive evasion in earnings call Q&A sessions. It also performs a thorough analysis of all insider transactions to pinpoint outliers that may forecast future over or underperformance. These data points are synthesized into the ManagementTrack Rating, a predictive 1-10 score for every executive, giving investors a clear, forward-looking view on how management’s ability will likely impact company results.
Q: How extensive is ManagementTrack’s coverage?
A: ManagementTrack delivers real-time coverage and analysis on the c-suite of every publicly listed company.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Author Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
Verified Career History by ManagementTrack for Jakob Just-Bomholt
Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
Elekta AB 10Q
Elekta AB 10K
Elekta AB Earnings Calls
Elekta AB Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
